Skip to main content
LIFECORE BIOMEDICAL, INC. \DE\ logo

LIFECORE BIOMEDICAL, INC. \DE\ — Investor Relations & Filings

Ticker · LFCR ISIN · US5147661046 LEI · 549300EHBZ5OM9ND9O43 US Manufacturing
Open in API
Filings indexed 1,096 across all filing types
Latest filing 2012-04-10 Director's Dealing
Country US United States of America
Listing US LFCR

About LIFECORE BIOMEDICAL, INC. \DE\

https://www.lifecore.com/

Lifecore Biomedical is an integrated contract development and manufacturing organization (CDMO) that specializes in sterile injectable pharmaceutical drug products and medical devices. The company provides a full range of services, including specialty formulation, process development, aseptic filling, and final packaging, supporting products from clinical phases through to commercial supply. A key area of expertise is the handling of complex and highly viscous formulations. In addition to its CDMO capabilities, Lifecore is a primary producer of non-animal-sourced sodium hyaluronate (hyaluronic acid), offering it in various molecular weights and formats, including bulk material, hydrogels, and filled syringes and vials for diverse applications.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2012-04-10 English
PRIMARY DOCUMENT
Director's Dealing
2012-04-04 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated March 30, 2012. The key content is the announcement of the retirement of a Chief Operating Officer, which is a change in senior management. There are no financial statements or detailed financial data present. The document is short (2095 characters) and focuses on management changes. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). Therefore, the correct classification is MANG with high confidence.
2012-04-02 English
FORM 4
Director's Dealing
2012-03-28 English
FORM 10-Q
Interim / Quarterly Report Q3 2012
2012-03-28 English
CURRENT REPORT
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report. It announces the issuance of a press release regarding the company's consolidated financial results for the third quarter of fiscal year 2012. The document itself does not contain the financial results but references an attached press release (Exhibit 99.1). The length of the document is 3022 characters, which is relatively short and primarily serves as an announcement of the earnings release rather than the earnings release itself. According to the 'Menu vs Meal' rule, such a document should be classified as an Earnings Release (ER) if it contains the initial announcement of quarterly financial results. Since the press release is attached and incorporated by reference, and the document is a Form 8-K announcing quarterly results, the best fit is Earnings Release (ER).
2012-03-26 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.